Clinical Trial Update: Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

View source ↗

Summary

This clinical trial aims to perform a comprehensive molecular analysis of endocrine neoplasms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Neoplasms
• Endocrine Tumors
• Neuroblastoma
• Parathyroid Neoplasms
• Thyroid Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Endocrine Tumors, Thyroid Neoplasms | Status: RECRUITING